Vetropolycin

Dechra Veterinary Products

VETROPOLYCIN® bacitracin-neomycin-polymyxin veterinary ophthalmic ointment

FULL PRESCRIBING INFORMATION: CONTENTS*

• VETROPOLYCIN DESCRIPTION
• ACTIONS
• INDICATIONS
• PRECAUTIONS
• VETROPOLYCIN ADVERSE REACTIONS
• VETROPOLYCIN DOSAGE AND ADMINISTRATION
• CAUTION
• WARNING
• HOW SUPPLIED
• PRINCIPAL DISPLAY PANEL - 3.5 g Tube Carton

FULL PRESCRIBING INFORMATION

STERILE - ANTIBACTERIAL

NADA # 065-016. Approved by FDA.

VETROPOLYCIN DESCRIPTION

Each gram contains Bacitracin Zinc 400 units, Neomycin Sulfate 5 mg (equivalent to 3.5 mg of Neomycin base), Polymyxin B Sulfate 10,000 units, in a base of White Petrolatum and Mineral Oil.

ACTIONS

The three antibiotics present in Vetropolycin® (bacitracin-neomycin-polymyxin) veterinary ophthalmic ointment provide a broad spectrum of activity against the gram-positive and gram-negative bacteria commonly involved in superficial infections of the eyelid and conjunctiva. Bacitracin is effective against gram-positive bacteria including hemolytic and non-hemolytic streptococci and staphylococci. Resistant strains rarely develop. Neomycin is effective against both gram-positive and gram-negative bacteria including staphylococci, Escherichia coli and Haemophilus influenzae and many strains of Proteus and Pseudomonas. Polymyxin B is bactericidal to gram-negative bacteria especially Pseudomonas. No resistant strains have been found to develop in vivo.

INDICATIONS

In the treatment of superficial bacterial infections of the eyelid and conjunctiva in dogs and cats when due to organisms susceptible to the antibiotics contained in the ointment. Laboratory tests should be conducted including in vitro culturing and susceptibility tests on samples collected prior to treatment.

PRECAUTIONS

Sensitivity to Vetropolycin® (bacitracin-neomycin-polymyxin) veterinary ophthalmic ointment is rare; however, if a reaction occurs, discontinue use of the preparation. As with any antibiotic preparation, prolonged use may result in the overgrowth of nonsusceptible organisms including fungi. Appropriate measures should be taken if this occurs. If infection does not respond to treatment in two or three days, the diagnosis and therapy should be re-evaluated.

Care should be taken not to contaminate the applicator tip of the tube during application of the preparation. Do not allow the applicator tip to come in contact with any tissue.

VETROPOLYCIN ADVERSE REACTIONS

Itching, burning or inflammation may occur in animals sensitive to the product. Discontinue use in such cases.

VETROPOLYCIN DOSAGE AND ADMINISTRATION

Apply a thin film over the cornea three or four times daily in dogs and cats. The area should be properly cleansed prior to the use of Vetropolycin® (bacitracin-neomycin­polymyxin) veterinary ophthalmic ointment. Foreign bodies, crusted exudates, and debris should be carefully removed.

CAUTION

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

WARNING

Do not use this product as a pre- surgical ocular lubricant. Adverse reactions of ocular irritation and corneal ulceration have been reported in association with such use.

HOW SUPPLIED

3.5 g (1/8 Oz) sterile tamper proof tubes.

NOC 17033-028-38.

STORE AT 15°-25°C (59°-77°F).

Manufactured for:
Dechra Veterinary Products
Overland Park, KS 66211.

lni0912
R1112

PRINCIPAL DISPLAY PANEL - 3.5 g Tube Carton

VETROPOLYCIN^®

NADA # 065-016. Approved by FDA.
NDC 17033-028-38.

bacitracin-neomycin-polymyxin
veterinary ophthalmic ointment

WARNING: Do not use this product as a
pre-surgical ocular lubricant. Adverse
reactions of ocular irritation and corneal
ulceration have been reported in
association with such use

STERILE - ANTIBACTERIAL

NET WT 3.5 g (1/8 Oz)

Dechra